Search

Your search keyword '"Rizzardini, Giuliano"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Rizzardini, Giuliano" Remove constraint Author: "Rizzardini, Giuliano" Journal journal of hepatology Remove constraint Journal: journal of hepatology
17 results on '"Rizzardini, Giuliano"'

Search Results

1. THU390 - Characterisation of baseline complement values in patients with chronic hepatitis B virus infection in the phase IIb B-clear study

2. Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study

Catalog

Books, media, physical & digital resources

3. Characterisation of baseline complement values in patients with chronic hepatitis B virus infection in the phase IIb B-clear study

4. Implementation of HCV screening in the 1969–1989 birth-cohort undergoing COVID-19 vaccination: a pivotal study in Italy

5. Distribution of patients by guideline-defined disease phase and/ or grey zones in B-Clear, an international multicentre clinical trial

6. Impact if HBV infection in HCV/HBV coinfected patients treated with DAAs in north Italy

7. Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

8. SAT453 - Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study

9. THU393 - Distribution of patients by guideline-defined disease phase and/ or grey zones in B-Clear, an international multicentre clinical trial

11. LB004B - Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study

12. THU-117-Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance

13. THU-175-Eligibility and feasibility of hepatitis C treatment in the era of direct-acting antiviral agents: Our experience in real-world practice

14. THU-180-Treatment of genotype 3 HCV infection in the large real-life “Navigatore Lombardia” multicentre cohort: Results from three different regimens

15. THU-133-Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience

16. Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

17. FRI401 - Impact if HBV infection in HCV/HBV coinfected patients treated with DAAs in north Italy